Toleranzia is a research company focused on the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology focused on the muscular disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaboration is done together with external partners within the field. The head office is based in Gothenburg.

Quotes for Toleranzia AB

Right Now

+/-
0.14
%
5,93%
Latest
2.5
High
2.57
Low
2.27
Volume
108 948
Turnover (SEK)
266 106
Value (MSEK)
50,5

Board

CEO

  • Charlotte Fribert

Chairman Of The Board

  • Ola Rönn

Board

  • Anders Milton
  • Anders Waas
  • Ann-Charlotte Rosendahl
  • Eva Lindgren
  • Jan Mattsson
  • Kristian Sandberg
  • Maarten Kraan

Videos

Largest Owners

Name Capital % Votes % Date
GU Ventures 12,15 12,15 2020-03-31
Robert Joki 7,15 7,15 2020-03-31
Sören Christensen 7,02 7,02 2020-03-31
Gunvald Berger 5,20 5,20 2020-03-31
Leo Graf 5,06 5,06 2020-03-31
Avanza Pension 3,69 3,69 2020-03-31
Nordnet Pensionsförsäkring 2,32 2,32 2020-03-31
Konstruktions o Försäljnings AB KFAB 2,18 2,18 2020-03-31
Nordea Liv & Pension 1,69 1,69 2020-03-31
Ola Hermansson 1,34 1,34 2020-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-08-28 Delårsrapport 2020-Q2

  • 2020-11-02 Delårsrapport 2020-Q3